Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN000082 | glyceraldehyde | 0.66 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 6,7-DICHLORO-3-HYDROXY-2-QUINOXALINECARBOXYLICACID | 0.78 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Phenylsulfate | 0.79 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | DICHLORODIPHENYLTRICHLOROETHANE | 0.8 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Bromopyruvicacid | 0.83 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2,3-Dichloro-4-(a-hydroxy-2-thenyl)phenoxyaceticacid | 0.83 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Ceramide(d18:1/26:1(17Z)) | 0.83 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Chloralhydrate | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | GPEtn(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | N-Lignoceroylsphingosine | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | GPSer(18:1(9Z)/18:2(9Z,12Z))[U] | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | SM(d18:0/16:0) | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | TacrolimusmetaboliteM-IV | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | CerP(d18:1/22:0) | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Cer(d18:0/18:0) | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Erythromycin | 0.84 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Histidine | 0.85 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | L-Serine | 0.85 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-(6-[5]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | 0.85 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Taurine | 0.85 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-(8-[3]-ladderane-octanoyl-2-(8-[3]-ladderane-octanyl)-sn-glycerol | 0.86 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | PROTOVERATRINEA | 0.86 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Arginine | 0.87 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | B-ureidoisobutyricacid | 0.87 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | beta-Alanine | 0.87 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | L-gamma-Cyano-gamma-aminobutyricacid | 0.87 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glucoheptonicacid | 0.88 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glycine | 0.88 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Oxaloglutarate | 0.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Hydroxyethanesulfonate | 0.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Gulonicacid | 0.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Acetazolamide | 0.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Ribonicacid | 0.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | D-Homoserine | 0.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glutaconicacid | 0.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Diacetyl | 0.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 4-Methylumbelliferylbeta-D-glucuronide | 0.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2,5-Dimethoxycinnamicacid | 0.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Chlorogenicacid | 0.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Mannitol | 0.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Methylglyoxal | 0.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Acetoaceticacid | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glycolaldehyde | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Dihydroxyacetone(glycerone) | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Lipoamide-0.91015834 | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | N-Acetyl-a-neuraminicacid | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glycolicacid | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Acetylaminodantrolene | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | L-arabitol | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyruvicacid | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Atovaquone | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Melphalan | 0.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Lactaldehyde | 0.92 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Amino-3-hydroxy-5-nitrobenzophenone | 0.92 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Succinicanhydride | 0.92 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | N-Acetylgalactosamine4-sulphate | 0.93 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Phosphatidylglycerol | 0.93 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Lipoamide | 0.93 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ISOEUGENITOL | 0.93 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | OXOLINICACID | 0.93 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyrocatechol | 0.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Quinicacid | 0.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ISOPIMPINELLIN | 0.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | MethoxsalenMetabolite | 0.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | cis-3-(6-Hydroxy-7-methoxy-5-benzofuranyl)acrylicacid-0.9427811 | 0.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | cis-3-(6-Hydroxy-7-methoxy-5-benzofuranyl)acrylicacid | 0.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2H-1-Benzopyran-6-aceticacid,7-hydroxy-8-methoxy-2-oxo- | 0.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | AspAsp | 0.95 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Creatine | 0.95 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glycericacid | 0.96 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | PURPUROGALLIN | 0.96 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | PYROGALLIN | 0.96 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Gummiferol | 0.96 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | beta-Alanine-0.95868075 | 0.96 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | S-Succinyldihydrolipoamide | 0.97 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Creatinine | 0.97 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Ribulose | 0.98 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 4,4-Bis(p-fluorophenyl)butyricacid | 0.99 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Sedoheptulose | 0.99 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | AspAsp-0.9946096 | 0.99 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Diacetyl-1.0001581 | 1 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | AspGlu | 1 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyruvicacid-1.0026177 | 1 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | cysteine | 1.01 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-Aminocyclopropane-1-carboxylicacid | 1.01 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Keto-glutaramicacid | 1.01 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Citraconicacid | 1.03 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Succinicanhydride-1.0287684 | 1.03 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | threo-Isocitricacid-1.0347548 | 1.03 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Methylglyoxal-1.0395479 | 1.04 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Furoicacid-1.0400704 | 1.04 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | N-Acetyl-L-Histidine | 1.05 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Zalcitabine | 1.09 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glutamate | 1.1 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Pyrrolidinone | 1.1 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | L-Asparticacidb-semialdehyde | 1.11 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyruvicacid-1.127027 | 1.13 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | isoamylnitrite | 1.19 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | L-Asparticacidb-semialdehyde-1.218115 | 1.22 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Diacetyl-1.2288649 | 1.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pseudouridine | 1.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Acipimox | 1.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Dihydromyricetin | 1.25 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Furoicacid | 1.25 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Acetoaceticacid-1.2563984 | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Furan2,5-dicarboxylicacid | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glutaconicacid-1.257499 | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Oxalaceticacid | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2,3-Dioxogulonicacid | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Dehydroascorbicacid | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | alpha-hydroxyisobutyrate-1.2596271 | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyruvicacid-1.2604657 | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 5,6-Dihydrouridine | 1.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Uricacid | 1.28 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Dihydroxyacetone(glycerone)-1.2817216 | 1.28 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Methylglyoxal-1.2867774 | 1.29 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Deoxyuridinemonophosphate(dUMP) | 1.29 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Deoxyribose | 1.29 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glyoxylicacid | 1.29 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyroglutamicacid | 1.3 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 3-(a-Naphthoxy)lacticacid | 1.3 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | cis-3-(6-Hydroxy-7-methoxy-5-benzofuranyl)acrylicacid-1.3130308 | 1.31 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-Hydroxy-2-naphthoicacid | 1.33 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Dihydroxyacetone(glycerone)-1.3654007 | 1.37 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyroglutamicacid-1.3865262 | 1.39 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-Hydroxy-2-naphthoicacid-1.3924078 | 1.39 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Furoicacid-1.418544 | 1.42 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Dihydroxyacetone(glycerone)-1.4241207 | 1.42 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyroglutamicacid-1.5248408 | 1.52 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Threonate | 1.53 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-Hydroxy-2-naphthoicacid-1.5557164 | 1.56 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | L-2-Aminoadipicacid | 1.61 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Imidazolone | 1.61 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Oxipurinol-1.6297603 | 1.63 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Oxipurinol | 1.66 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 3-Dehydroquinicacid | 1.67 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glutaconicacid-1.6951267 | 1.7 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glutaconicacid-1.7573386 | 1.76 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 3-Amino-3-(4-hydroxyphenyl)propanoate | 1.77 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | (S)-2-Hydroxyglutarate | 1.88 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 3-(Imidazol-4-yl)-2-oxopropylphosphate | 1.92 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | PenicillinG | 1.92 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | beta-Alanine-2.1040177 | 2.1 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glutamicacidg-semialdehyde | 2.11 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | alpha-hydroxyisobutyrate | 2.28 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Leucine | 2.3 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Biotinamide | 2.3 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Deoxyribose-2.4220703 | 2.42 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | BENZANTHRONE | 2.52 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | alpha-hydroxyisobutyrate-2.5388858 | 2.54 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Lactaldehyde-2.5392027 | 2.54 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Diphenylmethylphosphineoxide | 2.64 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | BENZANTHRONE-2.6784797 | 2.68 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | a-hydroxybutyrate | 2.68 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | EPIAFZELECHIN(2R,3R)(-) | 2.68 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Propionylglycinemethylester | 2.95 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | threo-Isocitricacid | 2.95 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 3-Deoxy-D-glycero-D-galacto-2-nonulosonicacid | 2.95 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-Hydroxy-2-naphthoicacid-2.9663975 | 2.97 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Fenofibrate | 2.99 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyruvicacid-3.0151846 | 3.02 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Ellagicacid | 3.05 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 4-Amino-7-chloroquinoline | 3.08 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Ribonicacid-3.0933578 | 3.09 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | MetLysSer | 3.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 8-hydroxymianseringlucuronide | 3.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Cilastatin | 3.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | GlyTyrAsn | 3.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-amino-4'-hydroxy-Propiophenone | 3.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ethylmalonicacid | 3.23 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | p-HYDROXYCINNAMALDEHYDE | 3.24 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Acetoin | 3.24 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ISOLIQUIRITIGENIN | 3.24 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | a-hydroxyisovalerate | 3.25 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1-Hydroxy-2-naphthoicacid-3.249221 | 3.25 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Fenoterolsulfate | 3.26 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 6-Methoxy-2-naphthylaceticacid | 3.28 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | BENZANTHRONE-3.2888675 | 3.29 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | beta-hydroxybutyrate | 3.4 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | PantothenicAcid | 3.43 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | BENZANTHRONE-3.462548 | 3.46 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Acetoin-3.5720763 | 3.57 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | BENZANTHRONE-3.5734656 | 3.57 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | a-hydroxyisovalerate-3.5743096 | 3.57 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Pyrocatecholsulfate | 3.61 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Tryptophan | 3.69 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | b-Glucose | 3.71 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ,4-Dihydroxyphenylpropionicacid | 3.73 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Methyl-3-ketovalericacid | 3.74 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | (R)-3-Methyl-2-oxobutanoate | 3.77 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | OSTHOL | 3.79 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Tetrahydrofuran | 3.79 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Hydroxythiopental | 3.79 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | BENZANTHRONE-3.7885036 | 3.79 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Glutaral(Glutaraldehyde) | 3.83 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Phenylsulfate-3.894887 | 3.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Phenol-3.8949444 | 3.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Methyl-3-ketovalericacid-3.9406526 | 3.94 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | N-gamma-Acetyl-N-2-formyl-5-methoxykynurenamine | 4.35 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | D-Biotin | 4.51 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 4-Hydroxytacrine | 4.9 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 3-Methylpimelicacid | 5.05 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | m-Salicylicacid | 5.47 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Phenol | 5.47 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | AsnGlnGln | 5.68 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Iridotrialglucoside | 5.73 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 3-Methylsubericacid | 5.76 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Parahydroxyphenylaceticacid | 6.07 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 6-Hydroxynicotinicacid | 6.19 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2,4-DINITROPHENOL | 6.67 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | N-Didesethylquinagolide | 6.82 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | altretamine | 8.05 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ORTHOTHYMOTINICACID | 8.32 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Embelin | 8.98 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | KOBUSONE | 8.98 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Procarbazine | 8.98 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | MetGluLys | 8.98 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Embelin-9.5837 | 9.58 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Metyrosine | 9.61 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 5-[2-(hydroxymethyl)-5-methylphenoxy]-2,2-dimethyl-Pentanoicacid(GemfibrozilM4) | 9.65 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Hydroxyethinylestradiol | 10.13 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 6b,11b,16a,17a,21-Pentahydroxypregna-1,4-diene-3,20-dione16,17-acetonide | 10.14 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | beta-D-Glucopyranosiduronicacid,2-(1H-indol-4-yloxy)-1-[[(1-methylethyl)amino]methyl]ethyl | 10.16 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | beta-D-Glucopyranosiduronicacid,2-(1H-indol-4-yloxy)-1-[[(1-methylethyl)amino]methyl]ethyl-10.241287 | 10.24 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | methyl8-[2-(2-formyl-vinyl)-3-hydroxy-5-oxo-cyclopentyl]-octanoate | 10.3 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-Hydroxyethinylestradiol-10.332443 | 10.33 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | clavuloneI | 10.68 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | TrpProHis | 10.68 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Isoacitretin-10.681391 | 10.68 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | TrpProHis-10.745563 | 10.75 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Isoacitretin | 10.75 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Embelin-10.833458 | 10.83 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ProHisTrp | 10.89 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Isoacitretin-10.914413 | 10.91 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | D1-2-Hydroxymethylethisterone | 11.18 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2H-Indol-2-one,4-[2-(dipropylamino)ethyl]-1,3-dihydro-7-hydroxy-glucuronide | 11.22 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | D1-2-Hydroxymethylethisterone-11.336955 | 11.34 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | D1-2-Hydroxymethylethisterone-11.481426 | 11.48 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Lauricacid | 11.85 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 7-hydroxy-10E,16-heptadecadien-8-ynoicacid | 12 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 9(S)-HODE-d4 | 12.08 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | LysTrpArg | 12.67 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | LysTrpArg-12.785133 | 12.79 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ANABASAMINE | 13.08 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 4,8-dimethyl-dodecanoicacid | 13.08 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | ProLysPro | 13.08 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | AlaPheArg | 14.14 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 2-propyl-tridecanoicacid | 14.14 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | 1alpha,25-dihydroxy-11alpha-phenylvitaminD3/1alpha,25-dihydroxy-11alpha-phenylcholecalciferol | 14.14 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000082 | Embelin-14.146105 | 14.15 | Minutes | ST000047 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid |